-3.jpg)
According to the lawsuit, Ronnie Glasper was prescribed either Naturalyte and/or GranuFlo during dialysis treatments at a Fresenius Medical Care center in Louisiana and ultimately suffered a heart attack and stroke.
The lawsuit alleges that on November 4, 2011, Fresenius sent an internal memo to certain Fresenius medical directors and physicians warning about the severe health risks associated with Naturalyte and GranuFlo, but did not warn the FDA about the risks, which were reportedly identified in a case-control study on hemodialysis patients. The memo allegedly noted that the case-control study found that “borderline elevated pre-dialysis bicarbonate levels and overt alkalosis were associated with six to eight fold greater risk of cardiopulmonary arrest and sudden cardiac death in the dialysis facility.”
READ MORE GRANUFLO RECALL LEGAL NEWS
Some patients who received Naturalyte or GranuFlo reportedly suffered from high blood serum bicarbonate levels, which can result in death, cardiopulmonary arrest, cardiac arrhythmias, stroke and other serious health problems.
Lawsuits have been filed against Fresenuis alleging patients were seriously harmed by the use of GranuFlo and Naturalyte. Eleven federal lawsuits were reportedly consolidated to MDL 2428 (In re: Fresenius GranuFlo/NaturaLyte Dialysate Products Liability Litigation) in the US District Court for the District of Massachusetts.